PharmaTher Holdings Ltd. (CSE:PHRM)

PharmaTher Holdings Financials Overview

Financials in millions CAD. Fiscal year is June - May.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Operating Income Operating Income Growth	-0.78	-0.78	-1.52	-3.04	-3.96	-3.96
Net Income Net Income Growth	-0.61	-0.61	-1.53	-3.12	-6.42	-4.01
Earnings Per Share EPS Growth	-0.01	-0.01	-0.02	-0.04	-0.07	-0.05
EPS Growth	-	-	-	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Net Cash (Debt) Net Cash Growth	0.92	0.92	1.12	2.3	6.25	12.12
Net Cash Growth	-17.95%	-17.95%	-51.16%	-63.22%	-48.41%	106.22%
Net Cash Per Share Net Cash Per Share Growth	0.01	0.01	0.01	0.03	0.07	0.15
Cash & Investments Cash & Investments Growth	0.92	0.92	1.12	2.3	6.25	12.12

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-0.49	-0.49	-1.21	-3.52	-3.24	-3.51
Capital Expenditures CapEx Growth	-	-	-	-	-	-
Free Cash Flow Free Cash Flow Growth	-0.49	-0.49	-1.21	-3.52	-3.24	-3.51
Free Cash Flow Growth	-	-	-	-	-	-

Valuation

Selected indicators aren't available for this stock.

Data Source: S&P Global Market Intelligence Last updated: Sep 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 8, 2026

Data Sources Report a data error